Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors.

MLA

Poletti, Sara, et al. “Lower Levels of Glutathione in the Anterior Cingulate Cortex Associate with Depressive Symptoms and White Matter Hyperintensities in COVID-19 Survivors.” European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, vol. 61, Aug. 2022, pp. 71–77. EBSCOhost, https://doi.org/10.1016/j.euroneuro.2022.06.008.

APA

Poletti, S., Paolini, M., Mazza, M. G., Palladini, M., Furlan, R., Querini, P. R., & Benedetti, F. (2022). Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors. European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, 61, 71–77. https://doi.org/10.1016/j.euroneuro.2022.06.008

Chicago

Poletti, Sara, Marco Paolini, Mario Gennaro Mazza, Mariagrazia Palladini, Roberto Furlan, Patrizia Rovere Querini, and Francesco Benedetti. 2022. “Lower Levels of Glutathione in the Anterior Cingulate Cortex Associate with Depressive Symptoms and White Matter Hyperintensities in COVID-19 Survivors.” European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology 61 (August): 71–77. doi:10.1016/j.euroneuro.2022.06.008.